Latest news
Edgewise Therapeutics Reports Second Quarter 2026 Financial Results - PR NewswirePR Newswire · Thu, 06 Aug 2026 12:00:00 GMTWindRose Health Investors Announces Recapitalization of Verified Clinical Trials - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:00:00 GMTSystImmune Announces First Patient Dosed in Global Phase 3 Trial of BL-M14D1 in First-Line Extensive-Stage Small Cell Lung Cancer - PR NewswirePR Newswire · Wed, 05 Aug 2026 12:00:00 GMT